DENTSPLY SIRONA (NASDAQ:XRAY) Cut to Strong Sell at Zacks Research

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Monday,Zacks.com reports.

XRAY has been the subject of a number of other reports. Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. JPMorgan Chase & Co. lowered their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Mizuho set a $13.00 price objective on shares of DENTSPLY SIRONA in a report on Friday. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Finally, Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Stock Down 0.2%

Shares of XRAY opened at $10.98 on Monday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a 50-day simple moving average of $12.86 and a 200-day simple moving average of $14.45. DENTSPLY SIRONA has a 52 week low of $10.69 and a 52 week high of $20.59. The firm has a market capitalization of $2.19 billion, a P/E ratio of -2.32, a P/E/G ratio of 0.81 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company’s revenue was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, equities research analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Trading of DENTSPLY SIRONA

Large investors have recently added to or reduced their stakes in the company. Trust Co. of Toledo NA OH acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $27,000. Parkside Financial Bank & Trust grew its position in DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,477 shares during the last quarter. Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at $26,000. Finally, Caitong International Asset Management Co. Ltd raised its position in DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 2,241 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.